• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Masimo recalls some Rad-G pulse oximeters

Masimo recalls some Rad-G pulse oximeters

May 16, 2024 By Danielle Kirsh

Masimo Rad-G pulse oximeter
The Rad-G pulse oximeter [Image courtesy of Rad-G pulse oximeter]
Masimo (Nasdaq: MASI) recently issued an urgent medical device recall notice for some Rad-G pulse oximeters.

The company issued the recall due to certain Rad-G devices powering off and on without pressing the power button. Masimo said the issue can result in an unintentional change in the device’s power state.

According to a company warning letter to customers, a loss of monitoring could happen if the device powers off unexpectedly, resulting in a potential delay in patient care.

Masimo has received 529 complaints related to this issue, with an occurrence rate of 3%. Two patient deaths have been reported while being monitored with the Rad-G devices. The company has not determined whether the devices powered off unexpectedly.

Masimo’s mitigation

The company recommends healthcare providers assess their inventory to confirm if they have the affected Rad-G devices and remove them from use.

Customers should also contact Masimo Technical Services to request repair or replacement of the affected part and serial numbers. Masimo also requests customers acknowledge receipt of the warning and return the customer warning notice.

More about the Rad-G pulse oximeter

The Rad-G provides clinically proven SET pulse oximetry, respiration rate from the pleth (RRp), and other vital parameters for both spot-checking and continuous monitoring, according to Masimo. It won FDA clearance in September 2020.

Other product descriptions and claims from Masimo include a long-lasting rechargeable battery, robust rubber casing, and lightweight. There’s also the new multipurpose, direct-connect Rad-G Sensor sensor for both adults and children.

The goal is to make it easier for clinicians to quickly assess patients and make informed care decisions anywhere pulse oximetry or vital signs checking is needed in a compact, portable form factor. The Rad-G can be used in a variety of settings, including physicians’ offices, outpatient services, long-term care facilities, wellness clinics, first-response scenarios, limited-resource environments and more.

Filed Under: Featured, Patient Monitoring, Recalls, Regulatory/Compliance Tagged With: Masimo

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy